Freeline to participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
LONDON, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that Theresa Heggie, Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on September 15 at 8.00 am EDT.
A live audio webcast of the fireside chat will be available on the investor relations section of Freeline’s website at https://www.freeline.life/investors-media/. An archived replay will be available on the Company’s website for a period of 30 days after the conference.
For further information, please reference the Company’s reports and documents filed with the U.S. Securities and Exchange Commission. You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.
Session Details TBA
Millimeter Wave: The Need for Speed
Protecting Critical Infrastructure with Epic Security